The latest breast cancer news
Browsing: Breast Cancer
The effect of breast cancer screening is declining
Screening for breast cancer has a cost. This is shown by a Danish/Norwegian study that…
EMA recommends olaparib for treatment of high-risk, early breast cancer
The Institute of Cancer Research, London, strongly welcomes the news that olaparib has been recommended…
Contrast-enhanced mammography vs MRI: Neoadjuvant therapy response in breast cancer
According to ARRS’ American Journal of Roentgenology (AJR), contrast-enhanced mammography (CEM) may be a useful alternative test…
A potentially more effective treatment for HER2 mutant metastatic breast cancer
Breast cancers with HER2 mutations respond to the drug neratinib, but the responses are variable…
Liquid biopsy detects DNA markers in advanced breast cancer within five hours
A novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer…
NICE recommends abemaciclib in combination with endocrine therapy for adjuvant treatment of HR+/HER2- early breast cancer
Abemaciclib in combination with endocrine therapy is the first CDK4/6 inhibitor to be made available within…
Breast cancer mainly spreads at night
Breast cancer is one of the most common forms of cancer, according to the World…
ASCO 2022: Novel agent increases PFS for patients with the most common type of advanced breast cancer
The use of sacituzumab govitecan (Trodelvy) an antibody-drug conjugate, resulted in longer progression-free survival compared to…
ASCO 2022: Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cancer to avoid radiation therapy
Based on guidance from biomarker screening, patients who are 55 years of age and older…
ASCO 2022: Novel antibody-drug conjugate doubles progression-free survival in metastatic breast cancer with low HER2 expression levels
The use of trastuzumab deruxtecan (Enhertu), a new HER2-targeting antibody-drug conjugate, doubled progression-free survival compared…